Mei-chang Huang
State Key Laboratory Of Oral Diseases & National Clinical Research Center For Oral Diseases & Department Of Oral Pathology
Chengdu, China
Chengdu, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Artemisinin suppressed tumour growth and induced vascular normalisation in oral squamous cell carcinoma via inhibition of macrophage migration inhibitory factor.
Journal: Oral diseases
Published: June 14, 2022
Retraction Note: Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: October 01, 2021
Expression of Ki-67, Cyclin D1, P53, and P16 in patients with oral leukoplakia and leukoplakia cancerization with spicy diet in Chengdu.
Journal: Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology
Published: August 19, 2021
Distinguishable Prognostic miRNA Signatures of Head and Neck Squamous Cell Cancer With or Without HPV Infection.
Journal: Frontiers in oncology
Published: October 06, 2020
Improvement program on pretreatment of acid decalcified tissue in hematoxylin-eosin staining
Journal: Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology
Published: June 24, 2020
Interplay between cancer cells and M2 macrophages is necessary for miR-550a-3-5p down-regulation-mediated HPV-positive OSCC progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: April 20, 2020
The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer.
Journal: Frontiers in immunology
Published: March 14, 2020
Susceptibility of Multiple Primary Cancers in Patients With Head and Neck Cancer: Nature or Nurture?
Susceptibility of Multiple Primary Cancers in Patients With Head and Neck Cancer: Nature or Nurture?
Journal: Frontiers in oncology
Published: September 05, 2019
Targeting Immune-Mediated Dormancy: A Promising Treatment of Cancer.
Journal: Frontiers in oncology
Published: March 05, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026